Combining low-dose or metronomic chemotherapy with anticancer vaccines: A therapeutic opportunity for lymphomas.
Therapeutic vaccination is regarded as a promising strategy against multiple hematological malignancies including lymphoma. However, this approach alone possesses limited potential for the treatment of established tumors. As several anticancer regimens relies on the combination of multiple drugs, it is reasonable to predict that also cancer vaccination will be most effective in the context of multimodal approaches. In particular, low-dose or metronomic chemotherapy could be coupled to anticancer vaccines to improve the efficacy of this immunotherapeutic interventions. This review summarizes recent findings in support of the use of anticancer vaccines combined with low-dose or metronomic chemotherapy for the treatment and management of lymphoid malignancies.
The University of Queensland Diamantina Institute; The University of Queensland; Translational Research Institute; Brisbane, Australia.
Heng
H
Sheng Sow
The University of Queensland Diamantina Institute; The University of Queensland; Translational Research Institute; Brisbane, Australia.
Stephen R
SR
Mattarollo
anticancer vaccines; immunotherapy; low-dose chemotherapy; lymphoma; metronomic chemotherapy